ELV Ramiro G. Peru bought Elevance Health, Inc. shares — SEC Form 4BUYElevance Health, Inc.

The stock is currently trading at $389.52, down 6.44% over the past five days but still up 20.58% over the last 90 days. It remains 10.17% below its 52-week high of $433.64.

• •Management raised full-year guidance after beating Q2 projections on July 16, 2026.
• •Bernstein SocGen Group raised its price target to $482 from $424 on July 16, 2026.
• •The trade is flagged as the largest insider purchase ever, signaling strong insider conviction.

• •A 'Medicaid Problem' is weighing on the stock, as the company exited additional underperforming Medicaid markets following its Q2 beat.
• •Big hospital systems are dropping Medicare Advantage plans, which could impact patient networks and revenue.